These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17951282)

  • 1. Antigliadin antibodies in Cuban patients with spinocerebellar ataxia type 2.
    Almaguer-Mederos LE; Almira YR; Góngora EM; Gotay DA; Zaldivar YG; Pupo RE; Cruz GS; Brown JM; Almarales DC; Pérez LV
    J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):315-7. PubMed ID: 17951282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antigliadin antibodies in ataxia patients.
    Abele M; Schöls L; Schwartz S; Klockgether T
    Neurology; 2003 May; 60(10):1674-5. PubMed ID: 12771263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia and the role of antigliadin antibodies.
    Wong D; Dwinnel M; Schulzer M; Nimmo M; Leavitt BR; Spacey SD
    Can J Neurol Sci; 2007 May; 34(2):193-6. PubMed ID: 17598597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis.
    Almaguer-Mederos LE; Falcón NS; Almira YR; Zaldivar YG; Almarales DC; Góngora EM; Herrera MP; Batallán KE; Armiñán RR; Manresa MV; Cruz GS; Laffita-Mesa J; Cyuz TM; Chang V; Auburger G; Gispert S; Pérez LV
    Clin Genet; 2010 Aug; 78(2):169-74. PubMed ID: 20095980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antigliadin antibodies in cerebellar ataxias: a systematic review and meta-analysis.
    Lin CY; Wang MJ; Tse W; Pinotti R; Alaedini A; Green PHR; Kuo SH
    J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1174-1180. PubMed ID: 29866704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
    Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
    J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone Levels Are Decreased and Associated with Disease Duration in Male Spinocerebellar Ataxia Type 2 Patients.
    Almaguer-Mederos LE; Aguilera-Rodríguez R; Almaguer-Gotay D; Hechavarría-Barzaga K; Álvarez-Sosa A; Chapman-Rodríguez Y; Silva-Ricardo Y; González-Zaldivar Y; Vázquez-Mojena Y; Cuello-Almarales D; Rodríguez-Estupiñán A
    Cerebellum; 2020 Aug; 19(4):597-604. PubMed ID: 32440846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive serum antigliadin antibodies without celiac disease in the elderly population: does it matter?
    Ruuskanen A; Kaukinen K; Collin P; Huhtala H; Valve R; Mäki M; Luostarinen L
    Scand J Gastroenterol; 2010 Oct; 45(10):1197-202. PubMed ID: 20545470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparison between antigliadin antibodies and blood xylose in celiac disease].
    Barbato M; Frediani T; Lucarelli S; Viola F; Iulinella VR; Cao M; Contestabile G; Farinelli C; Principessa L; Nobili V
    Minerva Pediatr; 1991 Sep; 43(9):563-6. PubMed ID: 1758392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial complex I gene variant associated with early age at onset in spinocerebellar ataxia type 2.
    Simon DK; Zheng K; Velázquez L; Santos N; Almaguer L; Figueroa KP; Pulst SM
    Arch Neurol; 2007 Jul; 64(7):1042-4. PubMed ID: 17620498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antigliadin antibodies in ataxia patients.
    Bushara K; Hallett M
    Neurology; 2004 Apr; 62(7):1237-8; author reply 1238. PubMed ID: 15079043
    [No Abstract]   [Full Text] [Related]  

  • 14. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study.
    Velázquez-Pérez L; Rodríguez-Labrada R; Canales-Ochoa N; Montero JM; Sánchez-Cruz G; Aguilera-Rodríguez R; Almaguer-Mederos LE; Laffita-Mesa JM
    Lancet Neurol; 2014 May; 13(5):482-9. PubMed ID: 24657153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive deficit in spinocerebellar ataxia type 2 is related to expanded CAG repeats: evidence from antisaccadic eye movements.
    Rodríguez-Labrada R; Velázquez-Pérez L; Aguilera-Rodríguez R; Seifried-Oberschmidt C; Peña-Acosta A; Canales-Ochoa N; Medrano-Montero J; Estupiñan-Rodríguez A; Vázquez-Mojena Y; González-Zaldivar Y; Laffita Mesa JM
    Brain Cogn; 2014 Nov; 91():28-34. PubMed ID: 25189938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: gluten intolerance beyond coeliac disease.
    Ruuskanen A; Luostarinen L; Collin P; Krekelä I; Patrikainen H; Tillonen J; Laurila K; Haimila K; Partanen J; Mäki M; Valve R; Kaukinen K
    Dig Liver Dis; 2011 Oct; 43(10):772-8. PubMed ID: 21641886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increasing prevalence of celiac children with negative serum antigliadin antibodies].
    Caristo E; Tognato E; Di Dio G; Rapa A; Fonio P
    Minerva Pediatr; 2010 Apr; 62(2):119-23. PubMed ID: 20440230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliadin antibodies in older population and neurological and psychiatric disorders.
    Ruuskanen A; Kaukinen K; Collin P; Krekelä I; Patrikainen H; Tillonen J; Nyrke T; Laurila K; Haimila K; Partanen J; Valve R; Mäki M; Luostarinen L
    Acta Neurol Scand; 2013 Jan; 127(1):19-25. PubMed ID: 22494246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigliadin antibodies in psoriasis.
    Sultan SJ; Ahmad QM; Sultan ST
    Australas J Dermatol; 2010 Nov; 51(4):238-42. PubMed ID: 21198518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative antigliadin antibody measurement in clinical practice: an Italian multicentre study. SIGEP Working Group on Quantitative AGA Standardization.
    Catassi C; Fabiani E; Gasparin M; Troncone R
    Ital J Gastroenterol Hepatol; 1999; 31(5):366-70. PubMed ID: 10470593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.